Inovio is a corporate strategic investor and biotechnology company focused on DNA medicines. It backs strategically aligned opportunities in biotechnology, life sciences, pharmaceuticals and oncology, with early-stage venture activity tied to therapeutic development. The company focuses on United States opportunities and is based in Plymouth Meeting, Pennsylvania.